473.7000 0.55 (0.12%)
NSE Feb 25, 2026 12:17 PM
Volume: 27,284
 

473.70
0.12%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma has lost -25.00% in the last 6 Months
More from Solara Active Pharma Sciences Ltd.
Recommended